{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:42:30Z","timestamp":1793313750767,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.toxicon.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T15:04:20Z","timestamp":1369321460000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["The rat Digit Abduction Score (DAS) assay: A physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Ron S.","family":"Broide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Ardila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Roger","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2013.05.004_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1468-1331.1999.tb00032.x","article-title":"Preclinical update on BOTOX\u00ae (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations","volume":"6","author":"Aoki","year":"1999","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"Aoki","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.05.004_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0041-0101(02)00086-7","article-title":"Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety","volume":"40","author":"Aoki","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.05.004_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.05.004_bib5","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2011.06.013","article-title":"Updates on the antinociceptive mechanism hypothesis of botulinum toxin A","volume":"17","author":"Aoki","year":"2011","journal-title":"Parkinsonism. Relat. Disord."},{"key":"10.1016\/j.toxicon.2013.05.004_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.05.004_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-1331.2006.01441.x","article-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations","volume":"13","author":"Bhidayasiri","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1526-4610.2010.01766.x","article-title":"Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program","volume":"50","author":"Blumenfeld","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2013.05.004_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.toxicon.2009.01.015","article-title":"Development of future indications for BOTOX","volume":"54","author":"Brin","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.05.004_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21343","article-title":"Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg","volume":"40","author":"Carli","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2013.05.004_bib11","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1073\/pnas.0903111106","article-title":"Engineering botulinum neurotoxin to extend therapeutic intervention","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxicon.2013.05.004_bib12","first-page":"R641","article-title":"Relationship between body mass, tissue metabolic rate, and sodium pump activity in mammalian liver and kidney","volume":"268","author":"Couture","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur. Urol."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.05.004_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17429590701523794","article-title":"Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications","volume":"9","author":"de Almeida","year":"2007","journal-title":"J. Cosmet. Laser Ther."},{"key":"10.1016\/j.toxicon.2013.05.004_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.toxicon.2013.05.004_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"issue":"Suppl. 4","key":"10.1016\/j.toxicon.2013.05.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib18","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1242\/jeb.017640","article-title":"Scaling of muscle architecture and fiber types in the rat hindlimb","volume":"211","author":"Eng","year":"2008","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib19","series-title":"Gray's Anatomy","article-title":"Myology: the muscles and fasciae of the leg","author":"Gray","year":"2000"},{"key":"10.1016\/j.toxicon.2013.05.004_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00128071-200910020-00002","article-title":"Botulinum toxin for hyperhidrosis: a review","volume":"10","author":"Grunfeld","year":"2009","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib21","series-title":"IDEA Personal Trainer","article-title":"Ankle flexion and extension","author":"Hitzmann","year":"2003"},{"key":"10.1016\/j.toxicon.2013.05.004_bib22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib23","first-page":"249","article-title":"Effect of temperature and body size on the metabolic rate of the Egyptian house mice Mus Musculus and the roof rat Rattus Rattus","volume":"4","author":"Hussein","year":"1991","journal-title":"J. Islamic Acad. Sci."},{"key":"10.1016\/j.toxicon.2013.05.004_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1533-2500.2008.00202.x","article-title":"Evidence for the use of botulinum toxin in the chronic pain setting \u2013 a review of the literature","volume":"8","author":"Jeynes","year":"2008","journal-title":"Pain Pract."},{"key":"10.1016\/j.toxicon.2013.05.004_bib25","first-page":"73","article-title":"Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion","volume":"117","author":"Lim","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.toxicon.2013.05.004_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2010.205","article-title":"Headache in 2010: progress in headache mechanisms and management","volume":"7","author":"Lipton","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mus.10272","article-title":"Juvenile and adult rat neuromuscular junctions: density, distribution, and morphology","volume":"26","author":"Ma","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2013.05.004_bib28","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/j.1460-9568.2007.05529.x","article-title":"Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C","volume":"25","author":"Morbiato","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.toxicon.2013.05.004_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1468-1331.2010.03130.x","article-title":"Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: international consensus statement","volume":"17","author":"Novak","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib30","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3390\/toxins2122890","article-title":"Botulinum neurotoxin for pain management: insights from animal models","volume":"2","author":"Pavone","year":"2010","journal-title":"Toxins. (Basel)"},{"key":"10.1016\/j.toxicon.2013.05.004_bib31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ACO.0b013e32833c3405","article-title":"The role of botulinum toxin in management of pain: an evidence-based review","volume":"23","author":"Qerama","year":"2010","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0270(03)00227-9","article-title":"LABORAS: initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour","volume":"130","author":"Quinn","year":"2003","journal-title":"J. Neurosci. Methods"},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2013.05.004_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1288\/00005537-199109000-00006","article-title":"Quantifying the spread of botulinum toxin through muscle fascia","volume":"101","author":"Shaari","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.toxicon.2013.05.004_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ucl.2010.06.001","article-title":"Botulinum toxin therapy for neurogenic detrusor overactivity","volume":"37","author":"Smaldone","year":"2010","journal-title":"Urol. Clin. North. Am."},{"key":"10.1016\/j.toxicon.2013.05.004_bib36","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AEM.30.3.420-423.1975","article-title":"Detection of Clostridium botulinum toxin by local paralysis elicited with intramuscular challenge","volume":"30","author":"Sugiyama","year":"1975","journal-title":"Appl. Microbiol."},{"key":"10.1016\/j.toxicon.2013.05.004_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.toxicon.2009.09.005","article-title":"Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins","volume":"55","author":"Torii","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.05.004_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0376-6357(00)00135-2","article-title":"Validation of a new system for the automatic registration of behaviour in mice and rats","volume":"53","author":"Van de Weerd","year":"2001","journal-title":"Behav. Process."},{"key":"10.1016\/j.toxicon.2013.05.004_bib40","doi-asserted-by":"crossref","first-page":"16993","DOI":"10.1074\/jbc.M710442200","article-title":"Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2013.05.004_bib41","first-page":"235","article-title":"An alternative in\u00a0vivo method to refine the mouse bioassay for botulinum toxin detection","volume":"61","author":"Wilder-Kofie","year":"2011","journal-title":"Comp. Med."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T02:16:12Z","timestamp":1595816172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010113001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":41,"alternative-id":["S0041010113001852"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.05.004","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rat Digit Abduction Score (DAS) assay: A physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}